Location History:
- Cadosia, NY (US) (2002 - 2004)
- Glenham, NY (US) (1996 - 2005)
- Amenia, NY (US) (2005)
Company Filing History:
17 out of 47 
4 out of 4 
1 out of 1 Years Active: 1996-2005
Title: Edward A Hunter: Innovator in Pharmaceutical Excipient Technologies
Introduction
Edward A Hunter is an esteemed inventor based in Glenham, NY. With an impressive portfolio of 23 patents, Hunter has made significant contributions to the field of pharmaceutical excipients. His work focuses on enhancing the properties and applications of microcrystalline cellulose, resulting in numerous advancements in solid dosage forms.
Latest Patents
Among Hunter's latest patents is a groundbreaking invention titled "Pharmaceutical excipient having improved compressibility." This patent describes a method of preparing an excipient composition that involves forming an aqueous slurry with a mixture of microcrystalline cellulose in a wet cake form, combined with a surfactant. The surfactant, present in a specific weight range, helps create a hydrophobic boundary at cellulose surfaces, improving the absorptivity of therapeutically active agents when mixed into dosage forms.
Another noteworthy patent is the "Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose." This innovation outlines an improved process for creating agglomerated solid dosage forms. The method integrates an active agent into an aqueous slurry containing microcrystalline cellulose and a compressibility augmenting agent, subsequently drying the slurry to prevent quasi-hornification.
Career Highlights
Edward A Hunter has a robust background in the pharmaceutical industry, having worked with reputable companies, including Edward Mendell Co., Inc. and J. Rettenmaier & Soehne GmbH + Co. KG. His experience in these prominent organizations has allowed him to significantly contribute to advancements in drug formulation and delivery.
Collaborations
Throughout his career, Hunter has collaborated with notable professionals in the field, including Bob E Sherwood and John N Staniforth. These partnerships have fostered an exchange of ideas, enhancing innovation in pharmaceutical excipients.
Conclusion
Edward A Hunter's innovative patents and collaborations showcase his dedication to improving pharmaceutical technologies. His ongoing contributions continue to shape the future of drug formulation, providing valuable advancements that support the development of effective therapeutic agents.